Antibiotico – resistenza in Campylobacter jejuni /coli in Italia nel corso del 2002: risultati di una indagine policentrica

Main Article Content

Daniele Crotti *
Maria Letizia D’Annibale
Mario Spinelli
Fernanda Lanzini
Stefano Rossi
Cinzia Rossi
Rosella Bruno
Maria Luisa Sangiorgio
Marina Bucci
(*) Corresponding Author:
Daniele Crotti | analisi.cliniche@ospedale.perugia.it

Abstract

During 2002, inside Campyg Working Group Project, we examined from 8 italian laboratories the patterns of resistances of 205 strains of Campylobacter spp.These strains were: 88% C. jejuni (68% biotype 1, 31% biotype 2, 1% biotype 3), 11% C. coli (95.5% biotype 1) and 1% Clo’s.We observed these resistances: to erythromycin 3.5% (2.2% in C. jejuni, 13.6% in C. coli), to rokitamicin 2.5 % (1.1% and 13.6% respectively), to ciprofloxacin 49.5% (51.1% and 63.6%), to tetracycline 45.0% (43.3% and 59.1%), to minocycline 41.6% (40.0% and 54.5%), to gentamycin 0.5%, to chloramphenicole no ones. Some differences concerning frequency of resistances were observed among 8 laboratories, also between C. jejuni b. 1 and C. jejuni b. 2, but these were not significative. Some suggests are given for continuing this surveillance, from an epidemiological point of view too.

Downloads

Download data is not yet available.

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.


Article Details

Most read articles by the same author(s)

<< < 1 2 3 > >>